/other/Diamyd_Medical_AB_publ-logo.png?Expires=1750012927&Signature=CzTFwfu0QDKzeT9ZppFFB7t4NM23o~qM3ib~8VtWoGDSlmhG4uUzzVfyQro4ilcze86TiQII8bO~2luJABtzWLknOzzStl-EDa6VtQWu82Yt7WJow5XPWQcogj8hkCQq~HpTJcQm5jb6Hm3ZbjfVfLShudp9YKokfe853EWT3v5l5SqhCU~FI8huIKzXaFF6ce0fh9mK05M0wiF92SPsORlQurpxeObC4Ew~~3G4alkFVZts81g463v-gdDY5z8bqH3OiPBanuskG7p3C6zaPib0kpej0efxRI~wi6D4FxB8ZKF9lfFGwsx4A5az74Qut4ysPqb3lekuFwbEDZmKrw__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Merck KGaA | United States of America | 6MK | |
| Metabolic Nordic AB | Sweden | MBOLIC | ||
|
Modus Therapeutics Holding AB | Sweden | MODTX | |
|
Molecure S.A. | Poland | MOC | |
|
M WINKWORTH PLC | United Kingdom | WINK | |
|
Mycodern Spolka Akcyjna | Poland | MCD | |
|
Nanexa AB | Sweden | NANEXA | |
|
Nanobiotix | France | NANO | |
|
Nanoform Finland OYJ | Finland | NANOFH | |
|
NanoGroup S.A. | Poland | NNG |